A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
Status:
RECRUITING
Trial end date:
2028-11-15
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma.